Rank | Gene Set | Z-score |
---|---|---|
1 | neuron cell-cell adhesion (GO:0007158) | 6.03551833 |
2 | presynaptic membrane assembly (GO:0097105) | 5.38607761 |
3 | vocalization behavior (GO:0071625) | 5.08001644 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.89732146 |
5 | protein localization to synapse (GO:0035418) | 4.89065556 |
6 | neuronal action potential propagation (GO:0019227) | 4.88903993 |
7 | postsynaptic membrane organization (GO:0001941) | 4.82713987 |
8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.80393107 |
9 | presynaptic membrane organization (GO:0097090) | 4.76880793 |
10 | behavioral response to nicotine (GO:0035095) | 4.67984340 |
11 | synaptic vesicle exocytosis (GO:0016079) | 4.65634710 |
12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.60273630 |
13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.57302861 |
14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.37493522 |
15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.36033265 |
16 | synaptic vesicle maturation (GO:0016188) | 4.28394075 |
17 | neuron recognition (GO:0008038) | 4.21434435 |
18 | locomotory exploration behavior (GO:0035641) | 4.20803634 |
19 | glutamate receptor signaling pathway (GO:0007215) | 4.20031440 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16546221 |
21 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.13801281 |
22 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.00833033 |
23 | gamma-aminobutyric acid transport (GO:0015812) | 3.99340186 |
24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95601625 |
25 | synaptic transmission, glutamatergic (GO:0035249) | 3.91277196 |
26 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.89910313 |
27 | positive regulation of membrane potential (GO:0045838) | 3.87624441 |
28 | positive regulation of synapse assembly (GO:0051965) | 3.83178301 |
29 | neurotransmitter secretion (GO:0007269) | 3.82861023 |
30 | regulation of synaptic vesicle transport (GO:1902803) | 3.81567303 |
31 | glutamate secretion (GO:0014047) | 3.72410737 |
32 | neuron-neuron synaptic transmission (GO:0007270) | 3.69569586 |
33 | layer formation in cerebral cortex (GO:0021819) | 3.65461103 |
34 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.64601588 |
35 | transmission of nerve impulse (GO:0019226) | 3.64545114 |
36 | axonal fasciculation (GO:0007413) | 3.59558032 |
37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57525812 |
38 | exploration behavior (GO:0035640) | 3.52494213 |
39 | neurotransmitter transport (GO:0006836) | 3.52363690 |
40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50631602 |
41 | regulation of respiratory system process (GO:0044065) | 3.48635939 |
42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.37868847 |
43 | C4-dicarboxylate transport (GO:0015740) | 3.31593287 |
44 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.30643372 |
45 | dendritic spine morphogenesis (GO:0060997) | 3.30477852 |
46 | long-term memory (GO:0007616) | 3.28553169 |
47 | membrane hyperpolarization (GO:0060081) | 3.27520209 |
48 | protein polyglutamylation (GO:0018095) | 3.26207481 |
49 | cerebellar granule cell differentiation (GO:0021707) | 3.24262471 |
50 | regulation of respiratory gaseous exchange (GO:0043576) | 3.24210167 |
51 | central nervous system myelination (GO:0022010) | 3.23807297 |
52 | axon ensheathment in central nervous system (GO:0032291) | 3.23807297 |
53 | negative regulation of astrocyte differentiation (GO:0048712) | 3.21123091 |
54 | dendrite morphogenesis (GO:0048813) | 3.20877567 |
55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.20204884 |
56 | mechanosensory behavior (GO:0007638) | 3.19095082 |
57 | membrane depolarization during action potential (GO:0086010) | 3.18669511 |
58 | negative regulation of neurotransmitter transport (GO:0051589) | 3.18544089 |
59 | auditory behavior (GO:0031223) | 3.16819770 |
60 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.16400427 |
61 | synapse assembly (GO:0007416) | 3.15402254 |
62 | long-term synaptic potentiation (GO:0060291) | 3.14708850 |
63 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14447998 |
64 | response to histamine (GO:0034776) | 3.13003470 |
65 | regulation of postsynaptic membrane potential (GO:0060078) | 3.07798812 |
66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.07184815 |
67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06849751 |
68 | regulation of neurotransmitter levels (GO:0001505) | 3.05166504 |
69 | positive regulation of action potential (GO:0045760) | 3.04988266 |
70 | serotonin metabolic process (GO:0042428) | 3.04974448 |
71 | regulation of synapse assembly (GO:0051963) | 3.04930566 |
72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.04542328 |
73 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.04502751 |
74 | regulation of neurotransmitter secretion (GO:0046928) | 2.97789356 |
75 | L-amino acid import (GO:0043092) | 2.97551001 |
76 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96148603 |
77 | regulation of meiosis I (GO:0060631) | 2.95912983 |
78 | neurotransmitter uptake (GO:0001504) | 2.95309239 |
79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94468189 |
80 | positive regulation of meiosis (GO:0045836) | 2.93558543 |
81 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.92622308 |
82 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.91358357 |
83 | primary amino compound metabolic process (GO:1901160) | 2.91274970 |
84 | proline transport (GO:0015824) | 2.91054070 |
85 | regulation of neurotransmitter uptake (GO:0051580) | 2.90637116 |
86 | retinal cone cell development (GO:0046549) | 2.89679571 |
87 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.89591779 |
88 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.89381134 |
89 | neuronal action potential (GO:0019228) | 2.89269413 |
90 | amino acid import (GO:0043090) | 2.87003958 |
91 | regulation of glutamate secretion (GO:0014048) | 2.86838734 |
92 | nucleobase catabolic process (GO:0046113) | 2.86616833 |
93 | membrane assembly (GO:0071709) | 2.86565406 |
94 | cell migration in hindbrain (GO:0021535) | 2.85237202 |
95 | piRNA metabolic process (GO:0034587) | 2.85038087 |
96 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.84999354 |
97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.83806726 |
98 | intraspecies interaction between organisms (GO:0051703) | 2.83140586 |
99 | social behavior (GO:0035176) | 2.83140586 |
100 | learning (GO:0007612) | 2.83009022 |
101 | protein localization to cilium (GO:0061512) | 2.82466794 |
102 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82403141 |
103 | fucose catabolic process (GO:0019317) | 2.81664661 |
104 | L-fucose metabolic process (GO:0042354) | 2.81664661 |
105 | L-fucose catabolic process (GO:0042355) | 2.81664661 |
106 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.80918495 |
107 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.80918495 |
108 | somite development (GO:0061053) | 2.79455654 |
109 | regulation of synapse structural plasticity (GO:0051823) | 2.79346654 |
110 | cell proliferation in forebrain (GO:0021846) | 2.79265100 |
111 | response to auditory stimulus (GO:0010996) | 2.78925403 |
112 | startle response (GO:0001964) | 2.78029484 |
113 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77954904 |
114 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.77523112 |
115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77489069 |
116 | cellular potassium ion homeostasis (GO:0030007) | 2.76977981 |
117 | regulation of dendritic spine development (GO:0060998) | 2.76913267 |
118 | synapse organization (GO:0050808) | 2.76582858 |
119 | regulation of synaptic plasticity (GO:0048167) | 2.76323710 |
120 | positive regulation of synapse maturation (GO:0090129) | 2.75348728 |
121 | protein-cofactor linkage (GO:0018065) | 2.75237548 |
122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.75139413 |
123 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.74759281 |
124 | response to amphetamine (GO:0001975) | 2.74595692 |
125 | retinal ganglion cell axon guidance (GO:0031290) | 2.74567947 |
126 | regulation of neurotransmitter transport (GO:0051588) | 2.74484747 |
127 | regulation of vesicle fusion (GO:0031338) | 2.73684852 |
128 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.72671741 |
129 | positive regulation of meiotic cell cycle (GO:0051446) | 2.68944215 |
130 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.66773874 |
131 | response to pheromone (GO:0019236) | 2.66342112 |
132 | otic vesicle formation (GO:0030916) | 2.63972164 |
133 | response to gravity (GO:0009629) | 2.58437759 |
134 | behavioral response to ethanol (GO:0048149) | 2.57649857 |
135 | atrial cardiac muscle cell action potential (GO:0086014) | 2.57356502 |
136 | adaptation of signaling pathway (GO:0023058) | 2.57032521 |
137 | dopamine biosynthetic process (GO:0042416) | 2.56484413 |
138 | nonmotile primary cilium assembly (GO:0035058) | 2.51596466 |
139 | regulation of action potential (GO:0098900) | 2.51025691 |
140 | potassium ion import (GO:0010107) | 2.49199993 |
141 | regulation of collateral sprouting (GO:0048670) | 2.48851949 |
142 | endoderm formation (GO:0001706) | 2.47879592 |
143 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.47190221 |
144 | detection of light stimulus involved in visual perception (GO:0050908) | 2.47190221 |
145 | photoreceptor cell development (GO:0042461) | 2.46864283 |
146 | action potential (GO:0001508) | 2.45707561 |
147 | DNA deamination (GO:0045006) | 2.45530764 |
148 | synaptic transmission, cholinergic (GO:0007271) | 2.45522914 |
149 | behavioral defense response (GO:0002209) | 2.44950538 |
150 | behavioral fear response (GO:0001662) | 2.44950538 |
151 | neurofilament cytoskeleton organization (GO:0060052) | 2.42401429 |
152 | DNA methylation involved in gamete generation (GO:0043046) | 2.42149581 |
153 | negative regulation of appetite (GO:0032099) | 2.42049295 |
154 | negative regulation of response to food (GO:0032096) | 2.42049295 |
155 | adult walking behavior (GO:0007628) | 2.40669544 |
156 | indole-containing compound metabolic process (GO:0042430) | 2.39767461 |
157 | appendage development (GO:0048736) | 2.39133461 |
158 | limb development (GO:0060173) | 2.39133461 |
159 | DNA double-strand break processing (GO:0000729) | 2.37792322 |
160 | neuromuscular synaptic transmission (GO:0007274) | 2.37641236 |
161 | anterograde axon cargo transport (GO:0008089) | 2.37160057 |
162 | reflex (GO:0060004) | 2.36967947 |
163 | axoneme assembly (GO:0035082) | 2.36896561 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75113303 |
2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.45886527 |
3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12310728 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99989837 |
5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92841625 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.77012736 |
7 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.71563477 |
8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58929477 |
9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48903515 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46103011 |
11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45208308 |
12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45208308 |
13 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41802144 |
14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36330357 |
15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.32525583 |
16 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30810839 |
17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30300494 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23070730 |
19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21844482 |
20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20480272 |
21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.17401168 |
22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13572271 |
23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.01429344 |
24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00457741 |
25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99765256 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97615271 |
27 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96758759 |
28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90622499 |
29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.89657564 |
30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.85030652 |
31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83924195 |
32 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82380451 |
33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81574509 |
34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.78559937 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73002564 |
36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72638985 |
37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71835409 |
38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71795790 |
39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70649067 |
40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65562065 |
41 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.65245878 |
42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.61366559 |
43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60058931 |
44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60048877 |
45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58739688 |
46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58392629 |
47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58252687 |
48 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57110072 |
49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.55606250 |
50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55377839 |
51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51772456 |
52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51727914 |
53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49710940 |
54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48931012 |
55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45637490 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44800238 |
57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.44338176 |
58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41410668 |
59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38610349 |
60 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36545618 |
61 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35334464 |
62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31977637 |
63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30783467 |
64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28905912 |
65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28659028 |
66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28428377 |
67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28428377 |
68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28011179 |
69 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27717485 |
70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27669951 |
71 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27366676 |
72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25555267 |
73 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24853512 |
74 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23916360 |
75 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23731461 |
76 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22700559 |
77 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21784951 |
78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21714945 |
79 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19769568 |
80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19304435 |
81 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17918212 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17403667 |
83 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17174847 |
84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15480087 |
85 | * JUN_21703547_ChIP-Seq_K562_Human | 1.15077514 |
86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15030988 |
87 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14610321 |
88 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14303524 |
89 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14222231 |
90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13486832 |
91 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12143042 |
92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12129632 |
93 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.10796715 |
94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10643870 |
95 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10299426 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10255468 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10179557 |
98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09425153 |
99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09330671 |
100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08689453 |
101 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07931609 |
102 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07931609 |
103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07732538 |
104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07443654 |
105 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07357903 |
106 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06748508 |
107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05769146 |
108 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05695287 |
109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05565015 |
110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03619614 |
111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03104545 |
112 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03025721 |
113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03025721 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02469047 |
115 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02085427 |
116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01608503 |
117 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01452575 |
118 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97924338 |
119 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97481370 |
120 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97249086 |
121 | AR_19668381_ChIP-Seq_PC3_Human | 0.96207617 |
122 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95609093 |
123 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92905532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 6.13937238 |
2 | MP0004859_abnormal_synaptic_plasticity | 4.34437084 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.53720371 |
4 | MP0009745_abnormal_behavioral_response | 3.23388866 |
5 | MP0002064_seizures | 3.18946814 |
6 | MP0009046_muscle_twitch | 3.16717014 |
7 | MP0004270_analgesia | 2.95207586 |
8 | MP0001968_abnormal_touch/_nociception | 2.87436773 |
9 | MP0002063_abnormal_learning/memory/cond | 2.80539224 |
10 | MP0005423_abnormal_somatic_nervous | 2.70822660 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.60424828 |
12 | MP0006276_abnormal_autonomic_nervous | 2.54673244 |
13 | MP0002734_abnormal_mechanical_nocicepti | 2.51929539 |
14 | MP0009379_abnormal_foot_pigmentation | 2.51100956 |
15 | MP0001486_abnormal_startle_reflex | 2.46619212 |
16 | MP0002272_abnormal_nervous_system | 2.43073897 |
17 | MP0008877_abnormal_DNA_methylation | 2.42804453 |
18 | MP0002736_abnormal_nociception_after | 2.38698618 |
19 | MP0001440_abnormal_grooming_behavior | 2.27235528 |
20 | MP0000778_abnormal_nervous_system | 2.24186927 |
21 | MP0002067_abnormal_sensory_capabilities | 2.14460849 |
22 | MP0002735_abnormal_chemical_nociception | 2.13893710 |
23 | MP0004043_abnormal_pH_regulation | 1.95188514 |
24 | MP0004142_abnormal_muscle_tone | 1.91059308 |
25 | MP0002733_abnormal_thermal_nociception | 1.81665422 |
26 | MP0001188_hyperpigmentation | 1.81157301 |
27 | MP0004885_abnormal_endolymph | 1.81133322 |
28 | MP0001970_abnormal_pain_threshold | 1.79984864 |
29 | MP0003011_delayed_dark_adaptation | 1.75807134 |
30 | MP0005645_abnormal_hypothalamus_physiol | 1.72521376 |
31 | MP0003787_abnormal_imprinting | 1.69512449 |
32 | MP0001529_abnormal_vocalization | 1.68627387 |
33 | MP0002557_abnormal_social/conspecific_i | 1.66954242 |
34 | MP0005253_abnormal_eye_physiology | 1.62160653 |
35 | MP0008569_lethality_at_weaning | 1.61398804 |
36 | MP0003122_maternal_imprinting | 1.57810137 |
37 | MP0002184_abnormal_innervation | 1.57506245 |
38 | MP0001501_abnormal_sleep_pattern | 1.55759931 |
39 | MP0004924_abnormal_behavior | 1.47683900 |
40 | MP0005386_behavior/neurological_phenoty | 1.47683900 |
41 | MP0002102_abnormal_ear_morphology | 1.47577900 |
42 | MP0001905_abnormal_dopamine_level | 1.47055583 |
43 | MP0004742_abnormal_vestibular_system | 1.46694908 |
44 | MP0001986_abnormal_taste_sensitivity | 1.44447602 |
45 | MP0002066_abnormal_motor_capabilities/c | 1.43511868 |
46 | MP0005409_darkened_coat_color | 1.41592723 |
47 | MP0005646_abnormal_pituitary_gland | 1.39932498 |
48 | MP0001984_abnormal_olfaction | 1.37767268 |
49 | MP0002882_abnormal_neuron_morphology | 1.37709067 |
50 | MP0002638_abnormal_pupillary_reflex | 1.36765947 |
51 | MP0008789_abnormal_olfactory_epithelium | 1.36602703 |
52 | MP0000920_abnormal_myelination | 1.34974602 |
53 | MP0002822_catalepsy | 1.34742785 |
54 | MP0000955_abnormal_spinal_cord | 1.34227661 |
55 | MP0002876_abnormal_thyroid_physiology | 1.23684812 |
56 | MP0004811_abnormal_neuron_physiology | 1.21533391 |
57 | MP0005551_abnormal_eye_electrophysiolog | 1.19591011 |
58 | MP0002653_abnormal_ependyma_morphology | 1.19191851 |
59 | MP0004133_heterotaxia | 1.18108778 |
60 | MP0003329_amyloid_beta_deposits | 1.17948717 |
61 | MP0001485_abnormal_pinna_reflex | 1.15055483 |
62 | MP0003121_genomic_imprinting | 1.11938674 |
63 | MP0002751_abnormal_autonomic_nervous | 1.11348320 |
64 | MP0002152_abnormal_brain_morphology | 1.09113416 |
65 | MP0001963_abnormal_hearing_physiology | 1.06326693 |
66 | MP0000427_abnormal_hair_cycle | 1.05784103 |
67 | MP0001765_abnormal_ion_homeostasis | 1.05215821 |
68 | MP0003136_yellow_coat_color | 1.03878980 |
69 | MP0002229_neurodegeneration | 1.03249340 |
70 | MP0003938_abnormal_ear_development | 1.03161834 |
71 | MP0000631_abnormal_neuroendocrine_gland | 1.01790978 |
72 | MP0005195_abnormal_posterior_eye | 1.01516295 |
73 | MP0000049_abnormal_middle_ear | 1.01243000 |
74 | MP0004145_abnormal_muscle_electrophysio | 1.01220038 |
75 | MP0003890_abnormal_embryonic-extraembry | 1.00639824 |
76 | MP0003879_abnormal_hair_cell | 0.99974567 |
77 | MP0002069_abnormal_eating/drinking_beha | 0.97563168 |
78 | MP0001177_atelectasis | 0.97213201 |
79 | MP0009780_abnormal_chondrocyte_physiolo | 0.97090419 |
80 | MP0005174_abnormal_tail_pigmentation | 0.96798219 |
81 | MP0003119_abnormal_digestive_system | 0.96004034 |
82 | MP0002234_abnormal_pharynx_morphology | 0.95263618 |
83 | MP0000026_abnormal_inner_ear | 0.94415975 |
84 | MP0001502_abnormal_circadian_rhythm | 0.93211648 |
85 | MP0003634_abnormal_glial_cell | 0.92943565 |
86 | MP0003937_abnormal_limbs/digits/tail_de | 0.91813595 |
87 | MP0003646_muscle_fatigue | 0.91429300 |
88 | MP0002752_abnormal_somatic_nervous | 0.89779956 |
89 | MP0010386_abnormal_urinary_bladder | 0.88009907 |
90 | MP0005084_abnormal_gallbladder_morpholo | 0.87011858 |
91 | MP0005389_reproductive_system_phenotype | 0.85686290 |
92 | MP0000538_abnormal_urinary_bladder | 0.85331101 |
93 | MP0003633_abnormal_nervous_system | 0.83803185 |
94 | MP0002160_abnormal_reproductive_system | 0.82539790 |
95 | MP0005535_abnormal_body_temperature | 0.80885260 |
96 | MP0001958_emphysema | 0.80020682 |
97 | MP0005499_abnormal_olfactory_system | 0.78677959 |
98 | MP0005394_taste/olfaction_phenotype | 0.78677959 |
99 | MP0005187_abnormal_penis_morphology | 0.78241382 |
100 | MP0003690_abnormal_glial_cell | 0.77882695 |
101 | MP0005171_absent_coat_pigmentation | 0.76379387 |
102 | MP0002909_abnormal_adrenal_gland | 0.75561228 |
103 | MP0003195_calcinosis | 0.75083163 |
104 | MP0001293_anophthalmia | 0.74738913 |
105 | MP0004858_abnormal_nervous_system | 0.74426776 |
106 | MP0003283_abnormal_digestive_organ | 0.73847852 |
107 | MP0003631_nervous_system_phenotype | 0.73531342 |
108 | MP0005391_vision/eye_phenotype | 0.73383162 |
109 | MP0005379_endocrine/exocrine_gland_phen | 0.72363702 |
110 | MP0002163_abnormal_gland_morphology | 0.70047117 |
111 | MP0001943_abnormal_respiration | 0.68934176 |
112 | MP0000751_myopathy | 0.66981220 |
113 | MP0008872_abnormal_physiological_respon | 0.64384376 |
114 | MP0003861_abnormal_nervous_system | 0.64033195 |
115 | MP0002837_dystrophic_cardiac_calcinosis | 0.60877773 |
116 | MP0002082_postnatal_lethality | 0.60113310 |
117 | MP0010770_preweaning_lethality | 0.60113310 |
118 | MP0003137_abnormal_impulse_conducting | 0.59857588 |
119 | MP0006292_abnormal_olfactory_placode | 0.59822716 |
120 | MP0000569_abnormal_digit_pigmentation | 0.58474624 |
121 | MP0001664_abnormal_digestion | 0.58151894 |
122 | MP0001299_abnormal_eye_distance/ | 0.57937630 |
123 | MP0010769_abnormal_survival | 0.57131336 |
124 | MP0005332_abnormal_amino_acid | 0.56622104 |
125 | MP0004215_abnormal_myocardial_fiber | 0.56574570 |
126 | MP0006072_abnormal_retinal_apoptosis | 0.56347904 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.47557821 |
2 | Increased circulating renin level (HP:0000848) | 4.50593199 |
3 | Hyperventilation (HP:0002883) | 4.49172254 |
4 | Atonic seizures (HP:0010819) | 4.34410398 |
5 | Focal seizures (HP:0007359) | 4.32931339 |
6 | Metabolic alkalosis (HP:0200114) | 4.23707580 |
7 | Hypomagnesemia (HP:0002917) | 4.13665903 |
8 | Progressive cerebellar ataxia (HP:0002073) | 3.77106096 |
9 | Epileptic encephalopathy (HP:0200134) | 3.74825185 |
10 | Absence seizures (HP:0002121) | 3.72915004 |
11 | Myokymia (HP:0002411) | 3.66585429 |
12 | Broad-based gait (HP:0002136) | 3.64691456 |
13 | Hypokalemic alkalosis (HP:0001949) | 3.50735419 |
14 | Visual hallucinations (HP:0002367) | 3.43010136 |
15 | Dialeptic seizures (HP:0011146) | 3.40681552 |
16 | Febrile seizures (HP:0002373) | 3.35667742 |
17 | Nephronophthisis (HP:0000090) | 3.32518290 |
18 | True hermaphroditism (HP:0010459) | 3.31464021 |
19 | Abnormality of magnesium homeostasis (HP:0004921) | 3.30662036 |
20 | Congenital stationary night blindness (HP:0007642) | 3.27904539 |
21 | Molar tooth sign on MRI (HP:0002419) | 3.26301843 |
22 | Abnormality of midbrain morphology (HP:0002418) | 3.26301843 |
23 | Hyperactive renin-angiotensin system (HP:0000841) | 3.23101010 |
24 | Pancreatic cysts (HP:0001737) | 3.23076981 |
25 | Polyphagia (HP:0002591) | 3.22525447 |
26 | Pancreatic fibrosis (HP:0100732) | 3.08675344 |
27 | Polyuria (HP:0000103) | 3.07946286 |
28 | Volvulus (HP:0002580) | 3.04667928 |
29 | Fetal akinesia sequence (HP:0001989) | 2.99691768 |
30 | Abnormal eating behavior (HP:0100738) | 2.97316932 |
31 | Type II lissencephaly (HP:0007260) | 2.95398024 |
32 | Generalized tonic-clonic seizures (HP:0002069) | 2.91046381 |
33 | Abnormal drinking behavior (HP:0030082) | 2.83335065 |
34 | Polydipsia (HP:0001959) | 2.83335065 |
35 | Drooling (HP:0002307) | 2.83020619 |
36 | Excessive salivation (HP:0003781) | 2.83020619 |
37 | Abnormality of the renal medulla (HP:0100957) | 2.81979087 |
38 | Abnormality of chloride homeostasis (HP:0011422) | 2.81901852 |
39 | Abnormality of renin-angiotensin system (HP:0000847) | 2.80820150 |
40 | Abnormal urine output (HP:0012590) | 2.75541351 |
41 | Progressive inability to walk (HP:0002505) | 2.68727537 |
42 | Abnormality of the renal cortex (HP:0011035) | 2.67200456 |
43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.59209807 |
44 | Gaze-evoked nystagmus (HP:0000640) | 2.57974140 |
45 | Intestinal atresia (HP:0011100) | 2.53430722 |
46 | Hyperaldosteronism (HP:0000859) | 2.51474017 |
47 | Oligodactyly (hands) (HP:0001180) | 2.50472890 |
48 | Hyperphosphaturia (HP:0003109) | 2.49952327 |
49 | Supranuclear gaze palsy (HP:0000605) | 2.48662110 |
50 | Abnormality of renal excretion (HP:0011036) | 2.47873264 |
51 | Optic nerve hypoplasia (HP:0000609) | 2.46818458 |
52 | Mutism (HP:0002300) | 2.44805145 |
53 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.42285401 |
54 | Anxiety (HP:0000739) | 2.38684562 |
55 | Dysmetria (HP:0001310) | 2.37523897 |
56 | Renal cortical cysts (HP:0000803) | 2.37066189 |
57 | Agitation (HP:0000713) | 2.36868937 |
58 | Mitochondrial inheritance (HP:0001427) | 2.36243495 |
59 | Sleep apnea (HP:0010535) | 2.35757291 |
60 | Congenital primary aphakia (HP:0007707) | 2.35477239 |
61 | Gout (HP:0001997) | 2.34364974 |
62 | Septo-optic dysplasia (HP:0100842) | 2.31368736 |
63 | Ankle clonus (HP:0011448) | 2.29187523 |
64 | Obstructive sleep apnea (HP:0002870) | 2.28450268 |
65 | Blue irides (HP:0000635) | 2.27945797 |
66 | Akinesia (HP:0002304) | 2.27563246 |
67 | Progressive macrocephaly (HP:0004481) | 2.27186102 |
68 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27126951 |
69 | Neurofibrillary tangles (HP:0002185) | 2.24704745 |
70 | Acute necrotizing encephalopathy (HP:0006965) | 2.24369605 |
71 | Tetany (HP:0001281) | 2.21635326 |
72 | Absent speech (HP:0001344) | 2.20981612 |
73 | Protruding tongue (HP:0010808) | 2.18751168 |
74 | Retinal dysplasia (HP:0007973) | 2.18639645 |
75 | Abnormal urine phosphate concentration (HP:0012599) | 2.18587955 |
76 | Abnormality of the labia minora (HP:0012880) | 2.17014654 |
77 | Dysdiadochokinesis (HP:0002075) | 2.16627509 |
78 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16467533 |
79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.14888588 |
80 | Dyskinesia (HP:0100660) | 2.14210978 |
81 | Truncal ataxia (HP:0002078) | 2.13968912 |
82 | Increased hepatocellular lipid droplets (HP:0006565) | 2.13856122 |
83 | Chronic hepatic failure (HP:0100626) | 2.12274869 |
84 | Gait imbalance (HP:0002141) | 2.12075805 |
85 | Abnormality of the corticospinal tract (HP:0002492) | 2.11625396 |
86 | Pendular nystagmus (HP:0012043) | 2.10801255 |
87 | Abnormality of renal resorption (HP:0011038) | 2.10401070 |
88 | Papilledema (HP:0001085) | 2.10201133 |
89 | Pachygyria (HP:0001302) | 2.09691240 |
90 | Genital tract atresia (HP:0001827) | 2.09496198 |
91 | Genetic anticipation (HP:0003743) | 2.09113621 |
92 | Lissencephaly (HP:0001339) | 2.08076354 |
93 | Abnormality of salivation (HP:0100755) | 2.07838900 |
94 | Acute encephalopathy (HP:0006846) | 2.07575543 |
95 | Inability to walk (HP:0002540) | 2.07476971 |
96 | Hyperthyroidism (HP:0000836) | 2.07444055 |
97 | Renal salt wasting (HP:0000127) | 2.05758961 |
98 | Hepatocellular necrosis (HP:0001404) | 2.05616255 |
99 | Hemiparesis (HP:0001269) | 2.04630425 |
100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04620036 |
101 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04620036 |
102 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.04225952 |
103 | Short tibia (HP:0005736) | 2.04111666 |
104 | Vaginal atresia (HP:0000148) | 2.02678514 |
105 | Poor eye contact (HP:0000817) | 2.01912051 |
106 | Renal Fanconi syndrome (HP:0001994) | 1.99910267 |
107 | Specific learning disability (HP:0001328) | 1.99588351 |
108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98275007 |
109 | Thickened helices (HP:0000391) | 1.96576085 |
110 | Abnormality of binocular vision (HP:0011514) | 1.96141923 |
111 | Diplopia (HP:0000651) | 1.96141923 |
112 | Sclerocornea (HP:0000647) | 1.95181966 |
113 | Stomach cancer (HP:0012126) | 1.95108296 |
114 | Cystic liver disease (HP:0006706) | 1.94982208 |
115 | Humeroradial synostosis (HP:0003041) | 1.93976743 |
116 | Synostosis involving the elbow (HP:0003938) | 1.93976743 |
117 | Action tremor (HP:0002345) | 1.92865563 |
118 | Oligodactyly (HP:0012165) | 1.92269197 |
119 | Postaxial foot polydactyly (HP:0001830) | 1.91921537 |
120 | Medial flaring of the eyebrow (HP:0010747) | 1.91828393 |
121 | Hemiplegia (HP:0002301) | 1.91269673 |
122 | Peripheral hypomyelination (HP:0007182) | 1.91253536 |
123 | Depression (HP:0000716) | 1.90861108 |
124 | Alkalosis (HP:0001948) | 1.90197855 |
125 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.89697127 |
126 | Asplenia (HP:0001746) | 1.89576663 |
127 | Epileptiform EEG discharges (HP:0011182) | 1.89341238 |
128 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.89301604 |
129 | Amblyopia (HP:0000646) | 1.88739133 |
130 | Generalized myoclonic seizures (HP:0002123) | 1.88447849 |
131 | Increased corneal curvature (HP:0100692) | 1.85775788 |
132 | Keratoconus (HP:0000563) | 1.85775788 |
133 | Nephrogenic diabetes insipidus (HP:0009806) | 1.85287723 |
134 | Ectopic kidney (HP:0000086) | 1.84397615 |
135 | Megalencephaly (HP:0001355) | 1.84096693 |
136 | Partial agenesis of the corpus callosum (HP:0001338) | 1.83659681 |
137 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.82911931 |
138 | EEG with generalized epileptiform discharges (HP:0011198) | 1.82805141 |
139 | Pheochromocytoma (HP:0002666) | 1.82164887 |
140 | Limb dystonia (HP:0002451) | 1.81420250 |
141 | Postaxial hand polydactyly (HP:0001162) | 1.80928478 |
142 | Methylmalonic acidemia (HP:0002912) | 1.80699474 |
143 | Abnormal social behavior (HP:0012433) | 1.80087834 |
144 | Impaired social interactions (HP:0000735) | 1.80087834 |
145 | Abnormal hair whorl (HP:0010721) | 1.79345840 |
146 | Gastrointestinal atresia (HP:0002589) | 1.79138571 |
147 | Status epilepticus (HP:0002133) | 1.78962453 |
148 | Cerebral inclusion bodies (HP:0100314) | 1.77138683 |
149 | Abnormality of glycolysis (HP:0004366) | 1.76800272 |
150 | Anencephaly (HP:0002323) | 1.75917185 |
151 | Attenuation of retinal blood vessels (HP:0007843) | 1.74433236 |
152 | Male pseudohermaphroditism (HP:0000037) | 1.73940832 |
153 | IgG deficiency (HP:0004315) | 1.73728824 |
154 | Hypothermia (HP:0002045) | 1.71518082 |
155 | Cerebellar dysplasia (HP:0007033) | 1.70215732 |
156 | Amyotrophic lateral sclerosis (HP:0007354) | 1.70126958 |
157 | Increased CSF lactate (HP:0002490) | 1.67386596 |
158 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.65598000 |
159 | 3-Methylglutaconic aciduria (HP:0003535) | 1.65067055 |
160 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.63970891 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 3.58485263 |
2 | MARK1 | 3.44712508 |
3 | OXSR1 | 3.43574756 |
4 | WNK4 | 3.21910046 |
5 | NTRK3 | 3.14818762 |
6 | WNK3 | 3.14217549 |
7 | STK39 | 3.00997787 |
8 | MAP2K7 | 2.86609536 |
9 | FRK | 2.74546273 |
10 | MAP3K4 | 2.59999762 |
11 | TNIK | 2.42371447 |
12 | TAOK3 | 2.35531991 |
13 | MAP4K2 | 2.29795403 |
14 | EPHA4 | 2.24163198 |
15 | MAP3K12 | 2.18311526 |
16 | MINK1 | 2.11971774 |
17 | PINK1 | 2.11076797 |
18 | ADRBK2 | 2.04671900 |
19 | GRK1 | 2.03891904 |
20 | PNCK | 2.01439650 |
21 | ACVR1B | 1.99852583 |
22 | MAPK13 | 1.89329262 |
23 | NME1 | 1.89291652 |
24 | MAP3K9 | 1.87628054 |
25 | NTRK2 | 1.82164170 |
26 | NUAK1 | 1.79893581 |
27 | CDK19 | 1.69303532 |
28 | FES | 1.66287378 |
29 | TXK | 1.63131827 |
30 | ZAK | 1.57420323 |
31 | PLK2 | 1.43621020 |
32 | KSR1 | 1.42184254 |
33 | PAK6 | 1.39240550 |
34 | BCR | 1.35639125 |
35 | UHMK1 | 1.34584657 |
36 | SIK2 | 1.32249287 |
37 | INSRR | 1.31846868 |
38 | MAP2K4 | 1.30313492 |
39 | DAPK2 | 1.23036073 |
40 | CDK5 | 1.22758865 |
41 | RIPK4 | 1.21345589 |
42 | PRKD3 | 1.19943865 |
43 | TRIM28 | 1.15293914 |
44 | SGK494 | 1.11980263 |
45 | SGK223 | 1.11980263 |
46 | MAP2K2 | 1.10661414 |
47 | DYRK1A | 1.06268925 |
48 | FGR | 1.03975815 |
49 | GRK7 | 1.03836510 |
50 | TLK1 | 1.02591827 |
51 | CAMK2A | 1.02209902 |
52 | STK38 | 1.00276733 |
53 | PKN1 | 0.99585426 |
54 | PRKCG | 0.97746634 |
55 | WNK1 | 0.95483627 |
56 | GRK5 | 0.93131223 |
57 | NTRK1 | 0.89203483 |
58 | CAMK2B | 0.87141163 |
59 | DYRK2 | 0.84288804 |
60 | STK11 | 0.82013014 |
61 | CDK14 | 0.79771109 |
62 | PLK4 | 0.78690160 |
63 | CSNK1G2 | 0.78521983 |
64 | IRAK2 | 0.76873917 |
65 | PRPF4B | 0.76870202 |
66 | CAMKK2 | 0.75315534 |
67 | CDK18 | 0.74495852 |
68 | MST4 | 0.74413708 |
69 | PAK3 | 0.74365884 |
70 | WEE1 | 0.73943392 |
71 | NEK6 | 0.73713136 |
72 | MAP3K13 | 0.73150904 |
73 | DMPK | 0.72582668 |
74 | LMTK2 | 0.70660586 |
75 | CDK15 | 0.70566894 |
76 | AKT3 | 0.70084079 |
77 | KSR2 | 0.68368298 |
78 | BMPR2 | 0.67305220 |
79 | PRKCE | 0.66986417 |
80 | PHKG1 | 0.66707694 |
81 | PHKG2 | 0.66707694 |
82 | LATS2 | 0.64586741 |
83 | MKNK2 | 0.64232139 |
84 | SGK1 | 0.63026077 |
85 | CDK11A | 0.62350339 |
86 | NLK | 0.59622599 |
87 | SGK2 | 0.59305581 |
88 | ROCK2 | 0.58715551 |
89 | CAMK2D | 0.57506613 |
90 | CSNK1G3 | 0.57307844 |
91 | CCNB1 | 0.52347713 |
92 | PRKCQ | 0.52026656 |
93 | TYRO3 | 0.51689753 |
94 | ADRBK1 | 0.50847435 |
95 | FGFR2 | 0.49355206 |
96 | CAMK1 | 0.48488377 |
97 | CAMK2G | 0.47994585 |
98 | VRK1 | 0.47969787 |
99 | EIF2AK2 | 0.47339487 |
100 | PTK2B | 0.47181845 |
101 | FER | 0.47112663 |
102 | BMPR1B | 0.46014763 |
103 | CSNK1G1 | 0.44542957 |
104 | MAP2K1 | 0.44533944 |
105 | PLK3 | 0.43805206 |
106 | MAPKAPK5 | 0.43582233 |
107 | BUB1 | 0.43506379 |
108 | FYN | 0.43264882 |
109 | SIK3 | 0.42968460 |
110 | EPHA3 | 0.42334442 |
111 | PRKCZ | 0.41995327 |
112 | CSNK1D | 0.40330903 |
113 | TIE1 | 0.40271709 |
114 | CDK3 | 0.39254744 |
115 | MAP3K2 | 0.39056132 |
116 | BCKDK | 0.38939939 |
117 | PRKACA | 0.38627926 |
118 | DAPK1 | 0.37037403 |
119 | RAF1 | 0.36741521 |
120 | ERBB4 | 0.36474635 |
121 | STK16 | 0.36450427 |
122 | MAPK15 | 0.36286813 |
123 | MUSK | 0.35475645 |
124 | PRKCH | 0.33709847 |
125 | PRKCA | 0.33293844 |
126 | ERBB3 | 0.32893979 |
127 | MARK2 | 0.32745163 |
128 | IRAK1 | 0.32689852 |
129 | MAP3K6 | 0.31797012 |
130 | CSNK1A1 | 0.31577455 |
131 | SGK3 | 0.31330737 |
132 | PRKG1 | 0.31194083 |
133 | CSNK1A1L | 0.31008554 |
134 | PIK3CA | 0.30992657 |
135 | EIF2AK1 | 0.30578819 |
136 | RPS6KA3 | 0.30403963 |
137 | TGFBR1 | 0.30342745 |
138 | ROCK1 | 0.30055801 |
139 | ERBB2 | 0.29752646 |
140 | RPS6KA5 | 0.29030684 |
141 | CAMK4 | 0.28826897 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.16879520 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.19944945 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.93442462 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76187940 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.75616924 |
6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49547262 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.48493440 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48418085 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.33405665 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26156719 |
11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.26029049 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.15736368 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.99835735 |
14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.98291163 |
15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.97313442 |
16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.93180537 |
17 | Long-term depression_Homo sapiens_hsa04730 | 1.86394468 |
18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84374662 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82783601 |
20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81808727 |
21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78944255 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.78840391 |
23 | Taste transduction_Homo sapiens_hsa04742 | 1.72207666 |
24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.69980266 |
25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67599497 |
26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66176252 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.63524344 |
28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59059810 |
29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.57589601 |
30 | Axon guidance_Homo sapiens_hsa04360 | 1.57180760 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54455759 |
32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.53980759 |
33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51942823 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.46924401 |
35 | Insulin secretion_Homo sapiens_hsa04911 | 1.46868365 |
36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.40337559 |
37 | Protein export_Homo sapiens_hsa03060 | 1.40138175 |
38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.39914978 |
39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39411727 |
40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33800338 |
41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29251616 |
42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28366195 |
43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27365697 |
44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26018940 |
45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.25094127 |
46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23583821 |
47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23481999 |
48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22094299 |
49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21584239 |
50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18298016 |
51 | Gap junction_Homo sapiens_hsa04540 | 1.18098836 |
52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17970593 |
53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15164629 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12250014 |
55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10208180 |
56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06380166 |
57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04574121 |
58 | RNA degradation_Homo sapiens_hsa03018 | 1.03151471 |
59 | Phototransduction_Homo sapiens_hsa04744 | 1.02567682 |
60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02486149 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99649393 |
62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95006036 |
63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92693363 |
64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92498519 |
65 | Glioma_Homo sapiens_hsa05214 | 0.88584864 |
66 | RNA polymerase_Homo sapiens_hsa03020 | 0.86057572 |
67 | Homologous recombination_Homo sapiens_hsa03440 | 0.85188801 |
68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85159177 |
69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84539575 |
70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84228986 |
71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82078632 |
72 | Peroxisome_Homo sapiens_hsa04146 | 0.81734465 |
73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80471343 |
74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76555998 |
75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74391899 |
76 | Melanogenesis_Homo sapiens_hsa04916 | 0.74034308 |
77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73727543 |
78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73626318 |
79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73016454 |
80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71389279 |
81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70729234 |
82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70701107 |
83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68276505 |
84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66727034 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66673383 |
86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65239032 |
87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64668802 |
88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.63454941 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62532762 |
90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62399916 |
91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61552739 |
92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61427380 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61092767 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61092445 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61086657 |
96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61056095 |
97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59302621 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58736030 |
99 | ABC transporters_Homo sapiens_hsa02010 | 0.55174805 |
100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54936808 |
101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54760018 |
102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54572496 |
103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54308809 |
104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54273991 |
105 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53965545 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49840125 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49342929 |
108 | Alcoholism_Homo sapiens_hsa05034 | 0.48704928 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48619339 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48603623 |
111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48187073 |
112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47434424 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.46720829 |
114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46093506 |
115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45425820 |
116 | Purine metabolism_Homo sapiens_hsa00230 | 0.44131787 |
117 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43666757 |
118 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42252366 |
119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40013986 |
120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38952447 |
121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38597990 |
122 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38537883 |
123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38531789 |
124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37971887 |
125 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37900534 |
126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35359061 |
127 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34759115 |
128 | Mineral absorption_Homo sapiens_hsa04978 | 0.34562947 |
129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34315818 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31837435 |
131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31052969 |
132 | Melanoma_Homo sapiens_hsa05218 | 0.30426578 |
133 | Endocytosis_Homo sapiens_hsa04144 | 0.30373673 |
134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30262965 |
135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27387586 |
136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26203505 |
137 | Bile secretion_Homo sapiens_hsa04976 | 0.24823162 |
138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21829388 |
139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.21625912 |
140 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19028391 |
141 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.16103198 |
142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.15541378 |
143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14983863 |